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Highlights 14 
• Turkey MIF was identified and its biological functions explored, including migration 15 
inhibitory activities of macrophages, cell proliferative activity, and induction of pro-16 
inflammatory as well as Th1/Th2/Th17 cytokines in activated immune cells. 17 
• Turkey and chicken MIFs share high sequence homology, functional similarities and 18 
cross-reactivity.  19 
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Abstract 20 
Macrophage migration inhibitory factor (MIF) is a soluble protein that inhibits the random 21 
migration of macrophages and plays a pivotal immunoregulatory function in innate and adaptive 22 
immunity.  The aim of this study was to clone the turkey MIF (TkMIF) gene, express the active 23 
protein, and characterize its basic function.  The full-length TkMIF gene was amplified from 24 
total RNA extracted from turkey spleen, followed by cloning into a prokaryotic (pET11a) 25 
expression vector.  Sequence analysis revealed that TkMIF consists of 115 amino acids with 12.5 26 
kDa molecular weight.  Multiple sequence alignment revealed 100%, 65%, 95% and 92% 27 
identity with chicken, duck, eagle and zebra finch MIFs, respectively.  Recombinant TkMIF 28 
(rTkMIF) was expressed in E. coli and purified through HPLC and endotoxin removal.  SDS-29 
PAGE analysis revealed an approximately 13.5 kDa of rTkMIF monomer containing T7 tag in 30 
soluble form.  Western blot analysis showed that anti-chicken MIF (ChMIF) polyclonal antisera 31 
detected a monomer form of TkMIF at approximately 13.5 kDa size.  Further functional analysis 32 
revealed that rTkMIF inhibits migration of both mononuclear cells and splenocytes in a dose-33 
dependent manner, but was abolished by the addition of anti-ChMIF polyclonal antisera.  qRT-34 
PCR analysis revealed elevated transcripts of pro-inflammatory cytokines by rTkMIF in LPS-35 
stimulated monocytes.  rTkMIF also led to increased levels of IFN-γ and IL-17F transcripts in 36 
Con A-activated splenocytes, while IL-10 and IL-13 transcripts were decreased.  Overall, the 37 
sequences of both the turkey and chicken MIF have high similarity and comparable biological 38 
functions with respect to migration inhibitory activities of macrophages and enhancement of pro-39 
inflammatory cytokine expression, suggesting that turkey and chicken MIFs would be 40 
biologically cross-reactive.  41 
Keywords: Macrophage migration inhibitory factor; turkey; chemotaxis; cytokines 42 
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1. Introduction 43 
Macrophage migration inhibitory factor (MIF), an evolutionarily conserved multi-44 
functional protein, was originally identified as activated T cell-derived factor inhibiting random 45 
migration of macrophages (David et al., 1966).  Following determination of complementary 46 
DNA sequence of human MIF (Weiser et al., 1989), a variety of biological properties has been 47 
reported and defined MIF as a cytokine, enzyme, and chemokine-like function (CLF) chemokine.  48 
MIF is constitutively expressed in a wide range of tissues and cells, and rapidly released after 49 
stimulation with Gram-negative bacteria, bacterial endotoxin (LPS), pro-inflammatory mediators 50 
(Calandra et al., 1994), and low concentration of glucocorticoids (Calandra et al., 1995).  Due to 51 
the absence of N-terminal consensus leader sequence, MIF is swiftly secreted through non-52 
classical pathway that requires the activation of the Golgi-associate protein p115a (Flieger et al., 53 
2003).   54 
As a pleiotropic inflammatory cytokine, MIF modulates both innate and adaptive immune 55 
responses through the activation of macrophages and T cells (Calandra et al., 2003).  MIF 56 
upregulates the expression of TLR4 in response to stimuli and prompts induction of pro-57 
inflammatory cytokines and chemokine (TNF-α, IFN-γ, IL-1β, IL-2, IL-6, IL-8), nitric oxide 58 
(NO) (Calandra et al., 1994; 1995; Bacher et al., 1996), and macrophage inflammatory protein 2 59 
(MIP2) (Makita et al., 1998).  In adaptive immunity, MIF inhibits CD8+ T lymphocytes (CTL) 60 
cytotoxicity and regulates T cell trafficking (Abe et al., 2001).  MIF reverses the anti-61 
inflammatory and immunosuppressive activities of glucocorticoids, and sustains inflammatory 62 
response against them (Calandra et al., 1995).  A high-affinity interaction of MIF with CD74 is 63 
responsible to induce cell proliferation by activation ERK ½ family of mitogen-activated protein 64 
in growth-promoting signaling pathway (Leng et al., 2003).  Induction of cyclooxygenase-2 65 
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(COX-2) and products of the arachidonic acid pathway (PGE2) by MIF is required to suppress 66 
apoptotic-inducing function of the tumor suppress protein (p53), which promotes cell survival 67 
(Mitchell et al., 2002).  Structural analysis revealed MIF exists as a homotrimer form, and two 68 
adjacent sites between monomers possess enzymatic activities (Lubetsky et al., 1999), such as a 69 
D-dopachrome tautomerase (Rosengren et al., 1996), a phenylpyruvate tautomerase (Rosengren 70 
et al., 1997), and a thiol-protein oxidoreductase (Kleemann et al., 1998).  Moreover, MIF is 71 
classified into CLF chemokine based on the structural and functional similarities with 72 
chemokines.  Comparison of crystal structure revealed that MIF monomer resembles the dimer 73 
form of CXCL8 (Weber et al., 2008).  The non-cognate interaction of MIF with chemokine 74 
receptors, CXCR2, CXCR4 and CXCR7, promotes chemotactic migration and leukocytes arrest 75 
(Bernhagen et al., 2007; Tarnowski et al., 2010).   76 
In birds, chicken MIF was identified as a marker for cellular differentiation in developing 77 
chicken eye lens (Wistow et al., 1993) and upregulated MIF transcript was observed in Eimeria-78 
infected chickens, thus supporting involvement of MIF in intestinal immune responses (Hong et 79 
al., 2006).  Molecular function of chicken MIF was characterized by analysis of cell migration, 80 
transcription of Th1/Th2-associated and pro-inflammatory cytokines, and cell proliferation after 81 
LPS stimulation (Kim et al., 2010).  Recently, it was verified that ChMIF binds to macrophages 82 
via the surface receptor CD74p41 (Kim et al., 2014). 83 
Compatative analyses of the turkey and chicken genomes revealed high similarity 84 
between the two sequences being relatively conservative and stable despite 40 million years of 85 
species divergence (Dalloul et al., 2010).  However, these two species showed lower similarity 86 
(83%) at the protein level than at the genome level (90%) (Arsenault et al., 2014).  To elucidate 87 
these distinctions at the protein level, further biological characterization is required.  To date, 88 
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several cytokines have been biologically characterized in turkeys, and also describing the cross-89 
reactivities of avian cytokines including IFN-γ, IL-2, IL-10, IL-13, and IL-18 (Lawson et al., 90 
2000; 2001; Kaiser et al., 2002; Powell et al., 2012).  91 
Given that these cytokines are functionally cross-reactive between two closely related 92 
Galliformes (turkey and chicken), MIF may also have a similar role in both species.  To describe 93 
the biological function of MIF in turkeys that may have cross-reactivity with chicken MIF, we 94 
cloned the full-length turkey MIF (TkMIF) gene, and explored its biological functions including 95 
inhibitory effect of random cell migration, proliferative effect of splenic lymphocytes, and 96 
expression of pro-inflammatory and Th1/Th2/Th17 cytokines by activated immune cells. 97 
 98 
2. Materials and Methods 99 
2.1. Turkey, RNA sources for cloning 100 
Tissue samples, including heart, liver, brain, thymus, spleen, small intestine sections 101 
(duodenum, jejunum, ileum), proventriculus, cecal tonsil and bursa, were collected from 21-day-102 
old male and female commercial turkey (Meleagris gallopavo).  A total of 30 mg tissue samples 103 
was excised and homogenized in lysis buffer containing β-mercaptoethanol (β-Me) with stainless 104 
steel beads using TissueLyser II (Qiagen, CA) for 5 min at 25 Hz.  Total RNA was isolated from 105 
homogenized tissues using the RNeasy Mini kit (Qiagen) according to the manufacturer’s 106 
instructions.   107 
 108 
2.2. Sequence analyses 109 
Nucleotide and deduced amino acid sequences of TkMIF were compared with other 110 
sequences reported in NCBI’s GenBank using Clustal Omega program (Sievers and Higgins, 111 
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2014).  The phylogenetic tree was constructed from the aligned sequences by the neighbor-112 
joining (NJ) method and evaluated with 1000 bootstrap replicates using MEGA4 (Tamura et al., 113 
2007).  The molecular weight (MW) and theoretical isoelectric point (pI) of MIF were computed 114 
using the Translate software.  The presence of signal peptide and potential N-glycosylation sites 115 
were predicted using SignalP3.0 and NetNGlyc 1.0, respectively.  The protein secondary 116 
structure of MIF was determined using SSpro 5.1 (Magnan and Baldi, 2014). 117 
 118 
2.3. Tissue distribution of TkMIF 119 
In order to analyze TkMIF expression in various tissues of male and female turkeys, 120 
qRT-PCR was performed using 7500 Fast Real-Time PCR system (Applied Biosystems, CA).  121 
Specific primer sets were designed using Primer Express (Ver 3.0; Applied Biosystems) (Table 122 
1).  First-strand cDNA was synthesized with 2 µg of total RNA from turkey tissues using High-123 
capacity cDNA Reverse Transcription kit (Applied Biosystems).  Synthesized cDNA was diluted 124 
to 1:25 with nuclease-free water and 1 µl of diluted cDNA was used as template with 0.1 µM 125 
primers and 5 µl of 2× Fast SYBR Green Master Mix (Applied Biosystems) in 10 µl volume of 126 
final qRT-PCR reaction.  The PCR reaction was performed as follows: samples were initially 127 
denatured at 95°C for 20 sec, followed by 40 cycles of denaturation at 95°C for 3 sec and 128 
annealing/extension at 57°C for 30 sec.  Reactions were prepared in triplicate and GAPDH was 129 
used as reference gene.  TkMIF expression was normalized to GAPDH and calculated relative to 130 
that of the heart by the 2−∆∆Ct comparative method. 131 
 132 
2.4. Construction of recombinant TkMIF (rTkMIF) expression plasmid 133 
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The full-length TkMIF gene was amplified from total RNA extracted from turkey spleen 134 
using primers designed by Kim et al. (2010) as follows: initial denaturation at 92°C for 2 min, 135 
followed by 35 cycles of denaturation at 92°C for 15 sec, annealing at 57°C for 15 sec, and 136 
extension at 72°C for 30 sec with a final extension at 72°C for 7 min.  The amplified PCR 137 
product was purified using Wizard SV Gel and PCR Clean-up system (Promega, WI), ligated 138 
into pGEM-T vector, and followed by transformation into E. coli Top10.  Transformants 139 
containing the target gene were selected by combination of colony PCR screening and 140 
endonuclease digestion with EcoR I (New England Biolabs, MA), confirmed by sequencing 141 
(Virginia Bioinformatics Institute at VT, VA).  For sub-cloning into a prokaryotic expression 142 
vector, TkMIF was digested with restriction endonucleases Nde I and Nhe I (New England 143 
Biolabs), and sub-cloned into the pET11a vector.  The recombinant plasmid was transformed 144 
into E. coli Top10 and positive clones including TkMIF were selected and confirmed by 145 
sequencing.   146 
 147 
2.5. Expression and purification of rTkMIF by SEC-HPLC 148 
The TkMIF in pET11a plasmid was transformed into E. coli BL21 (DE3) and cultured at 149 
30°C overnight and the production of recombinant TkMIF was induced by shake-incubating for 150 
5 hr in the presence of 1 mM IPTG.  The cells were harvested and lysed by rapid sonication-151 
freeze-thaw cycles in 20 mM NaH2PO4, 500 mM NaCl (pH 7.8), followed by treatment of RNase 152 
A (10 µg/ml) and DNase I (10 µg/ml) on ice for 15 min.  By centrifugation, the supernatant 153 
including rTkMIF was collected.  For endotoxin removal prior to purification, TX-114 (Sigma, 154 
MO) was added to the bacterial lysate containing rTkMIF to a final concentration of 1%.  The 155 
mixture was shortly vortexed and incubated at 41°C for 5 min, followed by centrifugation to 156 
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collect the upper aqueous phase containing rTkMIF.  This procedure was repeated three times.  157 
Subsequently, size exclusion high performance liquid chromatography (SEC-HPLC) was used to 158 
purify rTkMIF.  In SEC-HPLC, a mobile phase containing 50 mM K2HPO4, 150 mM NaCl (pH 159 
6.8) was passed through two size exclusion columns (7.7mm×300mm, Biosuite 5 µm HR; 160 
Waters, MA) at a rate of 0.5 ml/min and the absorbance was monitored with a photo diode array 161 
detector (Model 997; Waters, MA) at 214 nm and 280 nm.  Following injection of lysates, 162 
fractions were collected, analyzed by SDS-PAGE, and the concentration of proteins determined 163 
by BCA assay (Thermo Scientific, IL).  The level of endotoxin in purified protein sample was 164 
measured using Limulus Amebocyte Lysate (LAL) chromogenic endotoxin quantitation kit 165 
(Rockfold, IL).   166 
 167 
2.6. Western blot analysis 168 
Western blotting was performed to examine whether a rabbit anti-ChMIF polyclonal 169 
antisera (Kim et al., 2010) would recognize TkMIF as it shares high identity with ChMIF.  170 
Briefly, 1 ng of purified TkMIF was resolved on SDS-PAGE gel under reduced conditions, 171 
transferred to a PVDF membrane (Millipore, MA) and incubated with anti-ChMIF polyclonal 172 
antisera in a 1:1000 dilution as the primary antibody.  Goat anti-rabbit IgG conjugated with HRP 173 
(Thermo Scientific, IL) was applied as the secondary antibody and the blot was incubated in the 174 
SuperSignal® West Pico Chemiluminescent Substrate (Rockford, IL), and exposed to X-ray film 175 
(Genesee Scientific, CA).   176 
 177 
2.7. Isolation of peripheral blood mononuclear cells (PBMCs) and splenocytes 178 
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In order to perform cellular assay, turkey PBMCs were isolated from freshly drawn blood 179 
by density-gradient centrifugation.  Briefly, 20 ml of blood were collected from the heart 180 
(immediately following euthanasia) and diluted with equal volume of Hank’s Buffered Salt 181 
Solution without magnesium and calcium (HBSS; HyClone, UT).  Following centrifugation at 50 182 
x g for 10 min, the supernatant and buffy coat were collected and then carefully overlaid on 183 
Histopaque-1077 (Sigma, MO).  After centrifugation at 400 x g for 30 min at room temperature, 184 
mononuclear cells from the interphase were collected by Pasteur pipette and mixed with PBS for 185 
washing.  After centrifugation at 250 x g for 10 min, the collected cells were washed with 186 
Dulbecco’s Modified Eagle Medium (DMEM; Mediatech, VA), counted using a hemocytometer 187 
and cultured at 1.0×106 cells/well in a 24-well plate for 3 hr at 39°C with 5% CO2 humidified air.  188 
By gently washing with DMEM, non-adherent cells were removed leaving adherent 189 
monocytes/macrophages on the plate.  190 
For turkey splenocytes isolation, spleens were cut into small pieces and smashed through 191 
a 0.22 µm cell strainer (BD, CA).  Cell suspension was washed three times with HBSS to remove 192 
cell debris and overlaid onto Histopaque-1077, followed by isolation of splenocytes as described 193 
above.  Isolated splenocytes were resuspended with RPMI-1640 (Mediatech, VA) supplemented 194 
with 20% fetal calf serum (FCS) and 1% penicillin/streptomycin and cultured for 24 hr at 39°C 195 
with 5% CO2 humidified air.  After overnight incubation, non-adherent cells were collected and 196 
adjusted to a cell density of 2×106 cells/ml.   197 
 198 
2.8. Chemotaxis assay 199 
To measure the ability of TkMIF in inhibiting the random migration of immune cells, 200 
serially diluted rTkMIF (0.01, 0.1, 1.0 µg/ml) with DMEM supplemented with 10% FCS and 1% 201 
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penicillin/streptomycin were freshly prepared.  Diluted rTkMIF (25 µl) was loaded to the bottom 202 
wells of the Boyden chemotaxis chamber in absence or presence of anti-rChMIF polyclonal 203 
antisera along with the medium supplemented with 10% FCS and serum-free medium as positive 204 
and negative controls, respectively.  Polycarbonate filter membrane (Neuro Probe, MD) was 205 
placed with forceps and then 50 µl of prepared PBMCs or splenocytes (1.0×105 cells/ml) were 206 
loaded on the top well above the membrane.  After incubation at 39°C with 5% CO2 for 4 hr, 207 
cells that migrated to the bottom side of the membrane were fixed, stained using Diff-Quick 208 
Staining (Fisher Scientific, NJ) and counted.  The percentage of migration inhibition was 209 
calculated as previously described (Kotkes et al., 1979).  210 
 211 
2.9. Cell proliferation assay 212 
Cell proliferation was determined with CellTiter 96® Non-Radioactive Cell Proliferation 213 
Assay Kit (Promega, WI).  For this assay, isolated splenocytes (1.0×105 cells/ml) were treated 214 
with medium alone, Concanavalin A (Con A) alone (10 µg/ml), rTkMIF (0.01 and 0.1 µg/ml) or 215 
rTkMIF (0.01 and 0.1µg/ml) with Con A (10 µg/ml) in the presence or absence of anti-ChMIF 216 
polyclonal antibody at 39°C with 5% CO2 for 24 hr.  After incubation, the Dye solution was 217 
added and the mixture incubated at 39°C with 5% CO2 for 4 hr.  The Solubilization solution/Stop 218 
mix were added followed by incubation at 39°C with 5% CO2 for 1 hr, after which absorbance 219 
was measured at 595 nm and 630 nm using a microplate reader.  The results were analyzed after 220 
subtraction of the 630 nm value as a background.   221 
 222 
2.10. Cell stimulation assay and cytokine transcripts analysis 223 
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PBMCs were cultured at 2.0×106 cells/well in a 24-well plate and treated with medium 224 
alone, LPS alone (5 µg/ml), rTkMIF (0.01 and 0.1 µg/ml) or rTKMIF (0.01 and 0.1 µg/ml) with 225 
LPS (5 µg/ml) at 39°C with 5% CO2 for 6 hr.  The supernatants were collected for NO assay 226 
using Griess Reagent System (Promega, WI).  The cells were lysed with Buffer RLT (Qiagen) 227 
containing β-Me followed by RNA extraction using RNeasy Mini Kit (Qiagen).  After cDNA 228 
synthesis using 1 µg of RNA, expression levels of pro-inflammatory cytokines were analyzed.   229 
Isolated splenocytes were cultured at 2.0×106 cells/well in a 24-well plate and treated 230 
with medium alone, Con A alone (10 µg/ml), rTkMIF (0.01 and 0.1µg/ml) or rTKMIF (0.01 and 231 
0.1 µg/ml) with Con A (10 µg/ml) at 39°C with 5% CO2 for 6, 12, or 24 hr.  After incubation, 232 
NO assay was performed using the supernatant and total RNA was extracted.  After cDNA 233 
synthesis, the transcripts of Th1/Th2/Th17 cytokines were analyzed.   234 
 235 
2.11. Statistical analysis 236 
All data were analyzed by Student’s t-test or one-way analysis of variance (ANOVA) 237 
using JMP software (Ver 11) and significant differences between groups were considered 238 
significant by Tukey-Kramer multiple comparison test at P < 0.05.   239 
 240 
3. Results 241 
3.1. Sequence and phylogenetic analyses of TkMIF 242 
The full-length TkMIF amplified from turkey spleen contained 348 bp nucleotides 243 
encoding a 115-amino acid protein, which had 97% nucleotide and 100% amino acid identities 244 
with Chicken MIF (Figure S1 and Figure S2A).  Multiple sequence alignment and phylogenetic 245 
analysis revealed that TkMIF shares 71% identity with human and mouse MIFs, and over 61% 246 
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identity among bird species with the highest identity with eagle (95%) and zebra finch (92%) 247 
MIFs (Figure S2).  The phylogenetic tree shows that turkey MIF is closest to the chicken MIF as 248 
well as clusters together with eagle and zebra finch MIFs.  Similar to mammalian MIF and 249 
ChMIF, TkMIF retained conserved amino acid residues, Pro2, Lys33, Ile65, Tyr96, Asn98, which 250 
are essential for enzymatic activities.  The putative TkMIF showed a calculated MW of 12.5 kDa 251 
and theoretical isoelectric point of 7.82.  Computational analysis revealed two possible N-252 
glycosylations (73Asn-Lys-Thr75, 110Asn-Gly-Ser112) and four cysteine residues (Cys11, Cys57, 253 
Cys60, Cys81) in the amino acid sequence.  Cys11 is only conserved among the chicken, eagle, and 254 
zebra finch MIFs that are highly similar to TkMIF, and Cys57and Cys60 formed conserved Cys-255 
X-X-Cys motif mediated by enzymatic oxidoreductase activity.  Secondary structure of TkMIF 256 
exhibits two α-helices and six β-strands (Figure S1), similar to that of human MIF monomer.  257 
 258 
3.2. TkMIF expression in tissues 259 
The expression patterns of TkMIF gene was measured in various tissues of male and 260 
female turkeys including heart, liver, brain, thymus, spleen, proventriculus, cecal tonsils, bursa, 261 
and intestinal sections using qRT-PCR (Figure 1).  The expression level was normalized to 262 
GAPDH expression as an endogenous reference gene and then fold changes were calculated 263 
relative to the lowest expression level of heart.  The results demonstrated that TkMIF is 264 
ubiquitously expressed in all tested tissues, with the lowest level in the heart and relatively 265 
highest levels in the spleen and thymus in both males and females.  Slightly different expression 266 
levels were observed between males and females with high levels in ileum of females, but not in 267 
that of males.   268 
 269 
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3.3. Expression and Western analysis of TkMIF 270 
rTkMIF was expressed in E. coli BL21 (DE3) as a soluble form and 20% of protein from 271 
bacterial lysates was detected in predicted MW of rTkMIF on a gel after endotoxin removal by 272 
TX-114 extraction.  rTkMIF was purified and collected from fractions 19 and 20 by SEC-HPLC 273 
with 80% purity.  Purified rTkMIF was observed around 13.5 kDa by SDS-PAGE (Figure 2B, 274 
left), which is slightly higher molecular weight than that of only rTkMIF, 12.5 kDa due to the 275 
presence of T7 tag (approximately 1.3 kDa) in the recombinant protein that was encoded by the 276 
plasmid vector.  Endotoxin concentration of purified rTkMIF was 0.04 EU (endotoxin units) per 277 
µg protein.  Since turkey and chicken MIFs showed high identify, we examined whether anti-278 
ChMIF polyclonal antisera (Kim et al., 2010) can bind rTkMIF molecule (Figure 2B).  The anti-279 
ChMIF polyclonal antisera recognized 13.5 kDa of rTkMIF along with rChMIF, which was used 280 
as a positive control.  Based on the Western blot results, anti-ChMIF polyclonal antisera were 281 
used to neutralize rTkMIF in further assays.   282 
 283 
3.4. Chemotactic activity of rTkMIF 284 
In order to evaluate the regulation of PBMCs and splenocytes migration by rTkMIF, 285 
chemotaxis assay was performed.  Migration of PBMCs was inhibited by rTkMIF in a dose-286 
dependent manner, with 90% and 60% migration inhibition at high (1 µg/ml) and low (0.01 287 
µg/ml) concentration of rTkMIF, respectively (Figure 3A).  Although the inhibition level of cell 288 
migration is slightly lower than in PBMCs, rTkMIF also inhibited migration by approximately 289 
80% (1 µg/ml) and 10% (0.01 µg/ml) of splenic lymphocytes (Figure 3B).  The results show that 290 
rTkMIF has appreciable inhibition activity of migration on PBMCs as well as on splenocytes, 291 
revealing different inhibitory pattern between these two cell types.  Since 0.01 and 0.1 µg/ml of 292 
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rTkMIF showed noticeable reduction of both PBMCs and splenocytes migration, these two 293 
concentrations were used in subsequent assays. 294 
To substantiate its biological specificity, rTkMIF was neutralized using anti-ChMIF 295 
polyclonal antisera to examine whether MIF-induced inhibition of cell migration can be 296 
abolished.  Pre-incubation of rTkMIF (0.1 µg/ml) with anti-ChMIF polyclonal antisera blocked 297 
approximately 70% and 30% migration inhibition of PBMCs and splenocytes, respectively 298 
(Figure 4).  Anti-ChMIF antisera alone had no effect on migration of both PBMCs and 299 
splenocytes.   300 
 301 
3.5. The effect of rTkMIF on proliferation of splenic lymphocytes  302 
To determine the effect of rTkMIF on cell proliferation, isolated splenocytes were 303 
cultured with rTkMIF in the presence or absence of Con A (Figure 5).  We did not observe any 304 
significant changes in cell proliferation when treating with 0.01 µg/ml rTkMIF both in the 305 
presence and absence of Con A.  However, treatment with 0.1 µg/ml of rTkMIF slightly induced 306 
splenocytes proliferation.  Additionally, 0.1 µg/ml of rTkMIF enhanced proliferation of Con A 307 
co-stimulated splenocytes.  As percentages, 15% and 12% splenocyte proliferation were induced 308 
by 0.1 µg/ml of rTkMIF both in the presence and absence of Con A, respectively.  This rTkMIF-309 
induced splenocyte proliferation was abolished by pre-incubation with anti-ChMIF antisera, 310 
further substantiated its biological activity on cell proliferation.   311 
 312 
3.6. Expression of pro-inflammatory cytokines and chemokine by TkMIF in PBMCs 313 
The administration of rTkMIF alone did not affect cytokine expression (data not shown), 314 
but overall treatment of rTkMIF with LPS enhanced mRNA level of pro-inflammatory cytokines 315 
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(IL-1β, IL-6) and chemokine (IL-8) compared to those of LPS alone-treated cells (Figure 7).  316 
Transcripts of IL-1β and iNOS were enhanced approximately 14-fold and 19-fold, respectively, 317 
by incubation with 0.01 µg/ml rTkMIF but not with 0.1 µg/ml.  IL-1β transcript was enhanced by 318 
13-fold following 12 hr incubation (data not shown).  The addition of rTkMIF induced mRNA 319 
levels of IL-6 and IL-8 regardless of concentration, and markedly enhanced IL-8 transcript 320 
shown for 6 hr as well as 12 hr incubation.  LPS-stimulated PBMCs exhibited no significant 321 
induction of IL-12β (p40) and had reduced IL-18 transcript after 6 hr incubation with rTkMIF.  322 
However, enhanced IL-12β and IL-18 transcripts by 2-fold were shown at 12 hr incubation with 323 
0.01 µg/ml rTkMIF (data not shown).  In addition, the production of NO by PBMCs was 324 
observed after rTkMIF (0.01µg/ml) stimulation in combination with LPS, but not after treatment 325 
with rTkMIF alone (Figure 6).  326 
 327 
3.7. Expression of Th1/Th2/Th17 cytokines by TkMIF in splenocytes  328 
Splenocytes were treated with rTkMIF (0.01 and 0.1 µg/ml) in the presence of Con A for 329 
6, 12, and 24 hr (Figure 8).  Transcript of IFN-γ, a Th1 cytokine, was induced by Con A 330 
treatment, but no effect was observed by rTkMIF at 6 hr point; however, rTkMIF enhanced IFN-331 
γ transcript in a dose-dependent manner at 12 hr post-stimulation.  No difference in mRNA level 332 
was observed by Con A and/or rTkMIF at 24 hr post-stimulation.  On the other hand, rTkMIF 333 
reduced transcripts of Th2 cytokines (IL-10 and IL-13) after 24 hr stimulation; however, IL-10 334 
transcript was enhanced when the Con A-activated splenocytes were incubated with 0.1 µg/ml of 335 
rTkMIF at 6 hr.  rTkMIF significantly enhanced mRNA level of IL-17F over the tested 336 
incubation periods, especially 24 hr post-stimulation.  MIF transcript was not changed with 337 
either Con A treatment alone or Con A and rTkMIF treatment. 338 
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 339 
4. Discussion 340 
Previously, the molecular cloning and biological characterization of ChMIF have been 341 
described (Kim et al., 2010).  Interestingly, MIF homologue from turkey has high sequence 342 
identity with the corresponding gene of its sister Galliformes bird, the domesticated chicken.  343 
This finding led us to characterize the biological activities of TkMIF in order to compare this 344 
cytokine functions between two closely related Galliformes species (Kim et al., 2010).  In this 345 
study, we cloned the full-length MIF from domesticated turkey spleen and characterized its 346 
biological functions ex vivo.  Sequence analysis revealed that TkMIF contains conserved 347 
residues including CXXC motif mediating enzymatic activity, similar to human and mouse.  In 348 
addition, secondary structure analysis revealed that TkMIF possesses two α-helices and six β-349 
strands in the same order as mammalian MIF (Sun et al., 1996; Suzuki et al., 1996), implying a 350 
similar tertiary structure and function between turkey and mammalian MIFs.  The conserved 351 
sequences mediating enzymatic activities suggest the potential similar activities of TkMIF.  352 
However, catalytic activities were not exhibited in TkMIF in contrast to mammalian MIFs 353 
(Sugimoto et al., 1999).  Interestingly, a lack of catalytic properties also was exhibited in chicken 354 
MIF (Kim et al., 2010).  Also, TkMIF shares high homology with variant-1 of zebra finch among 355 
its two isoforms.  MIF is highly conserved among birds and mammals, indicating this molecule 356 
is evolutionary conserved across species and hence implying its significant function.   357 
MIF is ubiquitously expressed not only by immune cells as macrophages and activated T 358 
lymphocytes, but also by non-immune cells such as endothelial, epithelial and parenchymal cells 359 
(Lue et al., 2002; Calandra et al., 2003).  Consistent with the distribution patterns of MIF in 360 
various species, TkMIF was ubiquitously expressed in all tissues examined, and highly expressed 361 
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in the primary and secondary lymphoid tissues (thymus and spleen), in contrast to abundant 362 
ChMIF transcript in stomach (Kim et al., 2010).  Of note, only subtle differences were observed 363 
in TkMIF expression between male and female tissues.  Mammalian MIF is more expressed by 364 
monocytes and T lymphocytes, and up-regulated by stimulation with bacterial LPS and certain 365 
cytokines like IFN-γ and TNF-α (Calandra et al., 1994).  Although TkMIF is constitutively 366 
expressed, it is not significantly induced by stimulated monocytes and lymphocytes, similar to 367 
ChMIF (Kim et al., 2010).   368 
Like mammalian MIFs, TkMIF lacks an N-terminal signal sequence, indicating it is 369 
easily released from its intracellular stores as a soluble form via a non-conventional mechanism 370 
(Weiser et al., 1989).  As expected from high sequence identity between turkey and chicken 371 
MIFs, the ability of anti-ChMIF antisera to bind TkMIF was substantiated by performing 372 
Western blotting, which shows the cross reactivity of chicken MIF antibody against TkMIF.   373 
In the mouse, MIF regulated the recruitment of monocytes, T lymphocytes, and 374 
neutrophils like a CLF chemokine (Bernhagen et al., 2007).  The migration inhibitory properties 375 
of MIF on monocytes and lymphocytes were examined in the fish and further confirmed by 376 
neutralizing antibody (Qiu et al., 2013).  Consistent with previous reports, rTkMIF inhibited 377 
random migration of both monocytes and splenic lymphocytes in a dose-dependent manner.  378 
This inhibitory effect was abolished in the presence of anti-ChMIF polyclonal antisera, 379 
demonstrating that the observed inhibitory effect on the migration of immune cells was 380 
specifically associated with rTkMIF.  The rTkMIF exhibited similar pattern of chemotactic 381 
activity with ChMIF, suggesting that chemokine-like properties of MIF is conserved in both 382 
mammalian and avian species.  383 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Based on the finding that MIF was abundantly expressed in the epithelial cells of chicken 384 
embryonic lens (Wistow et al., 1993), MIF has been considered an important factor for cell 385 
growth and differentiation.  Mammalian MIF induced a survival cascade via interaction with 386 
CD74, resulting in B cell proliferation and survival (Starlets et al., 2006).  Immuno-387 
neutralization of MIF indicated its proliferative effect on splenocytes and T lymphocytes (Bacher 388 
et al., 1996; Calandra et al., 1998).  Additionally, MIF is secreted by murine dendritic cells (DCs) 389 
and neural stem/progenitor cells (NSPCs) that can support the proliferation and survival of 390 
NSPCs (Ohta et al., 2012).  In chickens, MIF induced proliferation of lymphocytes primed by 391 
Con A, although MIF alone did not impact cell proliferation.  In the present study, enhancement 392 
of cell proliferation was detected by addition of TkMIF on splenic lymphocytes both in the 393 
presence and absence of Con A stimulation.  The proliferative effect of TkMIF was suppressed 394 
by anti-ChMIF antisera.  These small but statistically significant effects support its ability to 395 
promote cell proliferation.   396 
Furthermore, MIF activated macrophages and induced significant production of pro-397 
inflammatory cytokines and NO in stimulated macrophages/monocytes (Bernhagen et al., 1994; 398 
Calandra et al., 1995).  In chickens, upregulated expression of pro-inflammatory cytokines and 399 
iNOS was shown in response to 0.01 µg/ml of rChMIF by LPS-primed monocytes/macrophages.  400 
The current findings that addition of TkMIF significantly augmented pro-inflammatory cytokines 401 
and chemokine (IL-1β, IL-6, IL-8) transcription and NO release by LPS-stimulated monocytes 402 
are consistent with previous reports.  TkMIF stimulation induced IL-12β and IL-18 at later time-403 
points when compared with other pro-inflammatory cytokines and chemokine.  These inductions 404 
may consequently result in synergistic action of IL-12β and IL-18 that would lead to IFN-γ 405 
production and stimulation of a Th1 response (Takeda et al., 1998).  Taken together, these data 406 
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support the pro-inflammatory roles of avian MIFs in stimulated immune cells.  Given that avian 407 
MIF promotes pro-inflammatory responses of innate immune cells, these findings suggest its 408 
potential role in host innate immune defenses of infected birds.  409 
In regards to MIF involvement in T cell immunity, murine MIF promoted Th1 cytokine 410 
production, typically IL-2 and IFN-γ, in activated T cells (Bacher et al., 1996).  In chickens, the 411 
production of Th1 and Th2 cytokines was regulated by MIF levels in Con A-stimulated 412 
lymphocytes (Kim et al., 2010).  In the present study, the addition of rTkMIF induced the 413 
expression of IFN-γ at 12 hr, and reduced transcripts of the Th2 cytokines IL-10 and IL-13 at 24 414 
hr.  The expression of IL-10 was briefly reduced and elevated after stimulation with low (0.01 415 
µg/ml) and high (0.1 µg/ml) concentrations of TkMIF at 6 hr, and then gradually decreased over 416 
24 hr.  Given the ability of avian IL-10 to inhibit IFN-γ expression by stimulated splenocytes 417 
(Rothwell et al., 2004; Powell et al., 2012), late enhancement of IFN-γ may be caused by gradual 418 
decline in IL-10 transcript combined with synergistic activity of IL-12β and IL-18.  As to the 419 
expression patterns of Th1 and Th2 cytokines in MIF-stimulated lymphocytes, TkMIF promoted 420 
Th1 transcript whereas suppressed Th2 transcripts, contrast to ChMIF that enhanced the 421 
transcript of both Th1 and Th2 cytokines.  These findings indicate different expression profiles 422 
of Th1 and Th2 between two species that may mediate the different susceptibilities to host-423 
specific pathogens; turkeys were extremely susceptible to Histomonas meleagridis exhibiting 424 
high mortality, while chickens were resistant to the parasite (Powell et al., 2009).  In this regard, 425 
it would be interesting to investigate whether MIF is associated with the susceptibility of turkeys 426 
to protozoan pathogens.  The stimulatory effect of MIF on IL-17 production was observed in 427 
activated murine lymphocytes (Stojanovic et al., 2009).  Similarly, rTkMIF continuously 428 
stimulated IL-17F production over the 24 hr incubation period, suggesting the possibility that 429 
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avian MIF might be involved in differentiation of Th17 cells.  Abundant MIF transcript by 430 
stimulation with PMA/ION was observed in mice (Bacher et al., 1996), whereas TkMIF was not 431 
significantly induced by LPS-stimulated splenic lymphocytes as well as monocytes from turkeys 432 
similar to chicken MIF, indicating that avian MIFs are constitutively expressed in immune cells 433 
regardless of stimulation.  These findings indicate the unique expression pattern of avian MIF 434 
contrast to most cytokines and chemokines that are expressed by activated cells.  TkMIF alone is 435 
not sufficient to induce cytokine expression in splenic lymphocytes as well as in monocytes, 436 
similar to results by ChMIF alone.  Overall, these data suggest that MIF can be directly involved 437 
in the modulation of Th1/Th2/Th17 cytokines in turkeys, further revealing different innate 438 
immune responses in stimulated cells between turkeys and chickens. 439 
In summary, Turkey MIF was cloned and its biological functions characterized including 440 
migration inhibitory effect, proliferative effect, and the ability to modulate production of pro-441 
inflammatory mediators as well as Th1/Th2/Th17 cytokines.  These results help us to better 442 
understand the biological roles of evolutionarily conserved avian MIFs in the birds’ immune 443 
system, and predict functional cross-reactivity between turkey and chicken MIFs.  444 
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Table 1.  Primers sequences used for gene cloning and qRT-PCR analysis. 579 
 580 
Name Sequence (5’→3’) GenBank accession 
No. 
Application 
TkMIF_F GATCATATGAGATCTATGCCCATGTTCACCATCCACACC  From turkey genome Gene cloning 
TkMIF_R GATGCTAGCCTATGCAAAGGTGGAACCGTTCCA 
MIF_F CGGATCCCTGCGCTCTCT XM_425824 qRT-PCR 
MIF_R TGTTCTGCTGCCCTCCGATT 
IFN- γ_F CAAAGCCGCACATCAAACAC AJ000725.1 
IFN- γ_R GCCATCAGGAAGGTTGTTTTTC 
IL-1b_F CCGACACGCAGGGACTTT DQ393271.1 
IL-1b_R GAAGGTGACGGGCTCAAAAA 
IL-2_F GAGCATCGCTATCACCAGAAAA AF209705.1 
IL-2_R TTGTTCTTGCTTTCTTCCAGTATTTCTA 
IL-6_F ACTCAGCCACCCAGAAATCC XM_003207130.1 
IL-6_R TCTCTATCCACGCCTTATCTGACT 
IL-8_F GGTTTCAGCAGCTCTGTCACA DQ393276.1 
IL-8_R TGGCACCGCAGCTCGTT 
IL-10_F CCAGCCACCAGGAGAGCAT AM493432.1 
IL-10_R GCGCTTCATTGTCATCTTCAG 
IL-12B_F ACTACTGTCCATTTGCCGAAGA XM_003210283.1 
IL-12B_R CATCAATGACCTCCAGGAACA 
IL-13_F CGAGCTCCATGCCCAAGAT AM493431.1 
IL-13_R TGTTGAGCTGCTGGATGCTT 
IL-17F_F GTCTCCAATCCCTTGTTCTCCTT XM_003204633.1 
IL-17F_R GACAGCACGGCCAGCAA 
IL-18_F TGCCCGTCGCATTCAG AJ312000.1 
IL-18_R CCATGCTCTTTCTCACAACACA 
iNOS_F TTGGGTGGAAGCCGAAAT XM_003211871.1 
iNOS_R TTGCTTGGAGAATGAGTGGAACT 
GAPDH_F GCTGAGAATGGGAAACTTGTGAT NM_001303179.1 
GAPDH_R GGGTTACGCTCCTGGAAGATAG 
  581 
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 582 
Figure 1.  Tissue-specific mRNA expression of TkMIF.  The relative TkMIF transcription in 583 
each tissue of male and female turkeys was calculated by the 2-∆∆Ct methods using GAPDH as a 584 
reference gene, and the relative expression level was compared with the expression level in heart 585 
(arbitrarily set at 1.0).  Error bars represent SEM.  586 
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 587 
 588 
Figure 2.  Purification and Western blot analysis of rTkMIF.  (A) rTkMIF was purified from 589 
bacterial lysate by SEC-HPLC and scanned the gel.  The fractions containing rTkMIF proteins 590 
are indicated by arrows.  (B) Purified rTkMIF was analyzed by SDS-PAGE analysis (left).  591 
Western blot analysis of rTkMIF was performed with anti-chicken MIF polyclonal antisera 592 
(1:1000) (right), MW, protein molecular weight marker; lane 1, rChMIF (1 ng); lane 2, rTkMIF 593 
(1 ng).   594 
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 595 
 596 
Figure 3.  Inhibition the random migration of PBMCs and splenocytes by rTkMIF.  Migration of 597 
turkey PBMCs-derived monocytes (A) and splenic lymphocytes (B) was observed in the 598 
presence of serially diluted rTkMIF (0.01, 0.1, and 1.0 µg/ml).  Experimental wells were set up 599 
in triplicate and values represent mean of two independent experiments.  Error bars represent 600 
SEM.  Asterisks (*) indicate statistically significant differences (*, ** = P < 0.05, 0.01, 601 
respectively).   602 
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 603 
Figure 4.  Blocking of MIF-induced inhibition of cell migration.  Migration of PBMC-derived 604 
monocytes and splenic lymphocytes were examined in the combination of rTkMIF (0.1 µg/ml) in 605 
the absence or presence of anti-ChMIF antisera (1:1000 dilution).  The experiment was set up in 606 
triplicate and data represent mean of two independent experiments.  Error bars represent SEM.  607 
Statistically significant differences indicated by asterisks (*, ** = P < 0.05, 0.01, respectively). 608 
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Figure 5.  The proliferative effect of rTkMIF on splenic lymphocytes.  1x105 cells were treated 610 
with media alone, Con A (10 µg/ml) alone, rTkMIF (0.01 and 0.1 µg/ml) alone, Con A with 611 
rTkMIF (0.01 and 0.1 µg/ml), rTkMIF (0.01, 0.1 µg/ml) with anti-rChMIF polyclonal antibody 612 
(1:1000 dilution) and Con A with anti-rChMIF polyclonal antisera in the absence or presence of 613 
rTkMIF (0.01 and 0.1 µg/ml) for 24 hr.  The cell proliferation assay was performed in triplicate 614 
per manufacturer’s instruction.  Data represent the mean of two independent experiments and 615 
significant differences are indicated by asterisks (P < 0.05).  Error bars represent SEM. 616 
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 618 
Figure 6.  Nitric oxide release of rTkMIF-treated PBMC derived monocytes.  Monocytes (1x106 619 
cells/well) were treated with media alone, rTkMIF (0.01 and 0.1 µg/ml) alone, LPS (5 µg/ml) 620 
alone, rTkMIF (0.01 and 0.1 µg/ml) with LPS (5 µg/ml) for 6 hr.  NO assay was performed in 621 
triplicate following the manufacturer’s instructions.  Data represent the mean of three 622 
independent experiments with significant differences indicated by asterisks (P < 0.05).  Error 623 
bars represent SEM.  624 
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 626 
Figure 7.  mRNA expression of pro-inflammatory cytokines and chemokine on rTkMIF treated 627 
monocytes.  PBMCs derived monocytes (1x106 cells/well) were treated with media alone, LPS 628 
(5 µg/ml) alone, rTkMIF (0.01 and 0.1 µg/ml) with LPS (5 µg/ml) for 6 hr and the expression of 629 
pro-inflammatory cytokines was examined by qRT-PCR.  Transcript levels were standardized to 630 
GAPDH and compared to media alone.  Data shown represent the mean of three different 631 
experiments with significant differences indicated by asterisks (*, ** = P < 0.05, 0.01, 632 
respectively).  Error bars represent SEM.  633 
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 635 
Figure 8.  mRNA expression of Th1/Th2/Th17 cytokines on rTkMIF treated splenocytes.  636 
Splenic lymphocytes (1x106 cells/well) were treated with media alone, Con A (10 µg/ml) alone, 637 
rTkMIF (0.01and 0.1 µg/ml) with Con A (10 µg/ml) for 6, 12, 24 hr and the expression of 638 
cytokines was examined by qRT-PCR.  Transcript levels were standardized to GAPDH and 639 
compared to media alone.  Data shown represent the mean of two independent experiments with 640 
significant difference of transcription compared to that of Con A alone indicated by asterisks (*, 641 
** = P < 0.05, 0.01, respectively).  Error bars represent SEM. 642 
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Highlights 14 
• Turkey MIF was identified and its biological functions explored, including migration 15 
inhibitory activities of macrophages, cell proliferative activity, and induction of pro-16 
inflammatory as well as Th1/Th2/Th17 cytokines in activated immune cells. 17 
• Turkey and chicken MIFs share high sequence homology, functional similarities and 18 
cross-reactivity. 19 
